It's not just a dream anymore: now more than ever, solutions are within our reach! Thanks to research, the life expectancy of those affected continues to increase. Our researchers need time to develop and identify lasting solutions that will contribute to preventing, treating and curing the disease. Meet some of the researchers who, thanks to your donations, are racing against time to beat this disease once and for all.
Dr. Turley studies non-melanoma skin cancer, also called carcinoma which affects close to 80,000 Canadians each year.
Dr. Francis Rodier and his team has discovered a therapeutic combination named "one two punch", which forces epithelial ovarian cancer cells to age maturely and keeps them from proliferating, thus causing their death.
Cancer is a very complex disease that affects everyone in some way. Basic research is essential to defeat this terrible illness. Unlike other diseases, cancer is caused by combinations of multiple genetic mutations, hence why the challenge is huge.
In 2018, Jim Petrik’s team published a study showing a winning therapy combination for a cancer known to be difficult to treat: ovarian cancer.
High fat diets are known to accelerate the growth of several cancer types including breast and colon. Our lab aims to study the links between fat metabolism and the progression of cancer.
All funds raised have been essential to initiate this critical research aimed at developing novel therapeutic strategies and targets to better treat the disease.
Kristan Aronson is investigating the complex relationship between shift work, melatonin, and the genes that control our internal clock.
Laurie Ailles and her team are using primary patient-derived cultures and tissues to gain a deep understanding of the epigenetic deregulation occurring in clear cell renal cell carcinoma
Different forms of cancer are driven by different changes to your cells. Finding unique properties in a cancer cell that sets it apart from a normal healthy cell is critical to develop effective therapies with low side effects.
Colorectal cancer is often found in members of a same family, suggesting a strong hereditary component.
Dr. Noël Raynal and his team at CHU Sainte-Justine in Montreal are looking at how drugs for heart failure treatment are protecting patients from cancer, and which cancers these drugs could be repurposed to combat.
I want to make a difference in the lives of brain cancer patients, who typically have a very poor prognosis and lack effective therapeutic options
Research on bladder cancer is underfunded and much work is needed to make major breakthroughs in its management.
The first grant I received came from the Cancer Research Society. Since 2003, the Society awarded me five operating grants. It is because of the Society’s donors that I was able to build my team of researchers.
Cancer affects us all. The disease is complex, and its treatments, varied. Our researchers are working on several fronts to defeat this terrible disease.
Your support plays a key role in funding research. Your donations are an investment in you, your family and generations to come.